« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 2
, Pages 343-347
, 1 October 2009
Survey of Stereotactic Body Radiation Therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group
References
- Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol. 1994;33:677–683
- Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Acta Oncol. 1995;34:861–870
- Extracranial stereotactic radiosurgery of localized targets. J Radiosurgery. 1998;1:135–148
- Radiosurgery for tumors in the body: Clinical experience using a new method. J Radiosurgery. 1998;1:63–74
- Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients. Cancer. 1998;82:1062–1070
- Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol. 2001;177:645–655
- Stereotactic single dose radiation therapy of liver tumors: Results of a phase I/II trial. J Clin Oncol. 2001;19:164–170
- Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience. Int J Radiat Oncol Biol Phys. 2001;51:666–670
- Clinical outcomes of 3D conformal hypofractionated single high dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2002;52:1041–1046
- Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest. 2003;124:1946–1955
- Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys. 2003;56:126–135
- Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer. 2003;40:309–315
- Stereotactic radiotherapy of primary lung cancer and pulmonary metastases: A non-invasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys. 2004;60:186–196
- Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung carcinoma. Cancer. 2004;101:1623–1631
- Clinical outcomes of a phase I/II of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63:1427–1431
- Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol. 2005;77:83–87
- Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer. 2005;48:107–114
- Stereotactic body radiation therapy for early stage non-small cell lung cancer: Phase I study. Int J Radiat Oncol Biol Phys. 2005;63:1010–1015
- A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys. 2005;62:1371–1378
- Treatment planning of stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 2005;61:1565–1571
- Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol. 2006;45:787–795
- . Stereotactic single-dose irradiation of stage I non-small cell lung cancer and lung metastases. Radiat Oncol. 2006;1:30
- . Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer—mature results for medically inoperable patients. Lung Cancer. 2006;51:97–103
- Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;66:117–125
- Clinical outcomes of single-fraction radiation therapy for lung tumors. Cancer. 2006;1006:1347–1352
- . Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin Radiat Oncol. 2006;16:77–84
- Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24:4833–4839
- Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol. 2006;45:838–847
- Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol. 2006;45:848–855
- . Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol. 2006;45:856–864
- Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24:4833–4839
Presented in part at the 5th Japan/US Cancer Therapy Symposium and the 5th Shinji Takahashi Memorial Joint Symposium, September 7–9, 2007, Sendai, Japan; and at the 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, November 5–9, 2006, Denver, Colorado.
The following institutes in Japan participated in this survey: National Defense Medical College, Yamanashi University, Tohoku University, Keio University, Osaka Rosai Hospital, Hokkaido University, Yamagata Saiseikan Hospital, Hiroshima University, Tokyo Metropolitan Hiroo Hospital, Oita National Hospital, Asahikawa Municipal Hospital, Kitazato University, Tokyo University, Nara Medical College, Kagoshima Satunan Hospital, Kobe IBRI Hospital, Saitama Medical College, NTT East Sapporo Hospital, Gifu University, Hakodate Municipal Hospital, Ibaraki Prefectural Central Hospital, Obihiro Kosei Hospital, Mie University, Chiba Cancer Center, Showa University, Kyushu University, Hyogo Medical Center for Adults, Nagasaki Prefectural Shimabara Hospital, Sapporo Municipal Hospital, Fukui Red Cross Hospital, Kameda General Hospital, Yamaguchi University, Daiyukai General Hospital, Musashino Red Cross Hospital, Hokkaido Cancer Center, Sapporo Medical College, Nihon University, Handa Municipal Hospital, Tenri Hospital, Saitama Cancer Center, Tokyo Medical College Hachioji Center, Aichi Cancer Center, Hiroshima Red Cross Hospital, Kobe University, Kashiwabara General Hospital, Hitachi General Hospital, Hirosaki University, Iwate Tanzawa Hospital, Sendai Kosei Hospital, Furukawa Municipal Hospital, Takeda General Hospital, Tokyo Metropolitan Komagome Hospital, Nagaoka Red Cross Hospital, Fukui University, Hiroshima Prefectural Hospital, Tokushima University, Kagawa University, Kumamoto University, West Kobe Medical Center, Jyuntendo University Hospital, Osaka Medical College, Asahikawa Kohsei Hospital, Gunma University, Japan Defense Structure Central Hospital, St. Luke's International Hospital, Maebashi Red Cross Hospital, Sagamihara Kyodo Hospital, Toyama Municipal Hospital, Shizuoka Saiseikai Hospital, Shiga University, Rinku Central Medical Center, Kurume University, Niigata Cancer Center, Aichi Medical College, Asanokawa General Hospital, Ehime University, Osaka University, Osaka City University, Osaka Red Cross Hospital, Osaka Medical Center for Cancer, Okayama University, Nagoya Second Red Cross Hospital, Kanazawa University, Kawasaki Medical College, Nagoya City University, Nagoya University, The Cancer Institute Hospital, Gifu Prefectural Hospital, Yokohama Municipal Hospital, Kyushu Cardiovascular Center, Kinki University, Konan St. Hill Hospital, National Cancer Center Hospital, National Cancer Center Hospital East, National Kure Hospital, Saga University, Shikoku Cancer Center, Shizuoka Cancer Center, Yokohama Rosai Hospital, Shizuoka General Hospital, Jichi University, JA Hiroshima General Hospital, Yamagata University, St. Marianna University, Seirei Hamamatsu General Hospital, Teikyo University, Tokai University, Tokyo Medical University, Tokyo Women's Medical University, Toyohashi Municipal Hospital, Nagasaki University, Nagoya National Hospital, and Kyoto University.
Conflict of interest: none.
PII: S0360-3016(09)00852-9
doi: 10.1016/j.ijrobp.2009.02.087
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 2
, Pages 343-347
, 1 October 2009
